Outside the pandemic, “investigational” remains payer code for denying reimbursement. In the case of treatment for chronic conditions, even FDA-approved digital-health and connected devices languish on waitlists for formulary inclusion.
Do patients really understand the true value associated with ownership and management of their healthcare data? It would appear not and this matters as a new raft of solutions hit the market